BioE Receives $8.3 Million in Funding From Private Investors

BioE, a biotechnology company developing antibody-based technology platforms for therapeutic and diagnostic applications, has received $8.3 million in its latest round of private financing.

PharmaLive (http://www.pharmalive.com/News/index.cfm?articleid=210417&categoryid=36%2C61)